CRHR1 Dimethylpyrazolotriazin derivatives preparation method thereof and pharmaceutical composition for use in preventing or treating CRHR1 related diseases containing the same as an active ingredient

The present invention relates to a dimethylpyrazolotriazine derivative, a method for manufacturing the same, and a pharmaceutical composition for preventing or treating CRHR1-related diseases comprising the same as an active ingredient. The compound represented by chemical formula 1 described herein has remarkably excellent metabolic stability. In addition, while exhibiting an excellent antagonistic effect on CRHR1, the present invention exhibits excellent effects in animal behavior experiments to confirm an antidepressant effect, thereby being expected to be useful for CRHR1-related diseases..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 27. Jan. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

KIM BYEONG MOON [VerfasserIn]
LIM TAEHYUN [VerfasserIn]
CHO HYUN SOO [VerfasserIn]
CHEONG EUNJI [VerfasserIn]
KIM HOYOUNG [VerfasserIn]
HA GO EUN [VerfasserIn]
CHANGNIENPING [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A23L: Foods, foodstuffs, or non-alcoholic beverages, not (...)
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che
tec

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-01-27, Last update posted on www.tib.eu: 2024-02-27, Last updated: 2024-03-01

Patentnummer:

KR20230013707

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA016408594